Companies/BioForce Nanosciences Holdings, Inc.
Company profile

BioForce Nanosciences Holdings, Inc.

OTC: BFNH · Consumer Defensive · Packaged Foods
#325 of 382 Consumer Defensive companies by revenue65th-percentile growth
EA Score
19D
Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$1.3M
Employees
3
as of 2026-08-19
Market cap
$128.8M
as of 2026-08-19

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$17.8k$17.8k2019
Net income-$1.3M-$1.3M2025
Operating income-$46.5k-$46.5k2019
Total assets$786$7862025
Liabilities$619.3k$619.3k2025
Equity-$618.5k-$618.5k2025

Revenue trend

FY2018 – FY2019 · USD
FY18
FY18
FY19

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is BioForce Nanosciences Holdings, Inc.’s revenue?

BioForce Nanosciences Holdings, Inc. booked $17.8k in FY2019 revenue, growing 9.0% year over yearfaster than most Consumer Defensive companies we track, at a -7268.4% net margin.

Key facts
CEORichard James Kaiser
SectorConsumer Defensive
IndustryPackaged Foods
HeadquartersVirginia Beach, VA
ExchangeOTC: BFNH
Employees3
IPO date2007-05-01
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.